Nalaganje...
Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges
Glioblastoma is the most common and lethal primary brain malignancy. Despite major investments in research into glioblastoma biology and drug development, treatment remains limited and survival has not substantially improved beyond 1–2 years. Cancer stem cells (CSC) or glioma stem cells (GSC) refer...
Shranjeno v:
| izdano v: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7945033/ https://ncbi.nlm.nih.gov/pubmed/33718170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.615704 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|